Xeris Pharmaceuticals Inc (XERS)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$3.02B
EV to revenue ratio (TTM)
8.11
EV to ebitda
88.40
Financial Performance
Revenue (TTM)
$0.37B
Gross profit (TTM)
$0.32B
EBITDA
$0.06B
Profitability
Operating margin (TTM)
12.70%
Profit margin
-1.76%
Return on assets (TTM)
7.37%
Return on equity (TTM)
-27.10%
Per Share Metrics
Revenue per share (TTM)
$2.13
EPS
-$0.03
Diluted EPS (TTM)
-$0.03
Book value
$0.27
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
n/a
Trailing P/E
n/a
Forward P/E
67.57
PEG ratio
n/a
Price to sales ratio (TTM)
8.20
Price to book ratio (TTM)
59.27
Growth
Quarterly earnings growth (YoY)
44.20%
Quarterly revenue growth (YoY)
1,616.00%
Analyst Sentiment
Strong buy
1
Buy
5
Hold
1
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.84